Lv0
0 积分 2025-10-06 加入
ASCT, CAR T-cell, or Combined Consolidation for R/R PCNSL in Re-achieved CR: An Inverse Probability of Treatment Weighting-Adjusted Comparative Study
1个月前
已完结
Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion
1个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
6个月前
已完结
Three-year follow-up analysis of first-line axicabtagene ciloleucel for high-risk large B-cell lymphoma: the ZUMA-12 study
8个月前
已完结
Acute lymphocytic leukaemia
11个月前
已完结
Frontline treatment of adults with newly diagnosed B-cell acute lymphoblastic leukaemia
11个月前
已完结
Management of B‐Cell Acute Lymphoblastic Leukemia
11个月前
已完结
Frontline immunotherapeutic combination strategies in adult B-cell acute lymphoblastic leukemia: reducing chemotherapy intensity and toxicity and harnessing efficacy
11个月前
已完结
Adult Acute Lymphoblastic Leukemia: 2025 Update on Diagnosis, Therapy, and Monitoring
11个月前
已完结
皖公网安备34019202002308
